ethylisopropylamiloride has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wiley, JS | 1 |
Jamieson, GP | 1 |
Mayger, W | 1 |
Cragoe, EJ | 1 |
Jopson, M | 1 |
Gaidano, G | 1 |
Ghigo, D | 1 |
Schena, M | 1 |
Bergui, L | 1 |
Treves, S | 1 |
Turrini, F | 1 |
Cappio, FC | 1 |
Bosia, A | 1 |
2 other studies available for ethylisopropylamiloride and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
Extracellular ATP stimulates an amiloride-sensitive sodium influx in human lymphocytes.
Topics: Adenosine Triphosphate; Amiloride; Biological Transport; Dose-Response Relationship, Drug; Humans; H | 1990 |
Na+/H+ exchange activation mediates the lipopolysaccharide-induced proliferation of human B lymphocytes and is impaired in malignant B-chronic lymphocytic leukemia lymphocytes.
Topics: Aged; Amiloride; B-Lymphocytes; Carrier Proteins; Child; Female; Humans; Hydrogen-Ion Concentration; | 1989 |